Migraine Treatment

Olla, Danielle; Sawyer, Justin D.; Sommer, Nicole Z.; Moore, John B.

doi:10.1016/j.cps.2020.01.003

Cited by 19 publications

(15 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“… 24 Botulinum toxin, nerve blocks, and neurostimulation have been tested to support these theories. 25 Surgery has been introduced as a complementary treatment option for patients in whom pharmacological control of the disease could not be achieved. Decompression/avulsion of specific extracranial trigeminal branches or of the occipital nerves and cauterization/ligation of extracranial arteries represent the mainly described treatments in the literature.…”

Section: Discussionmentioning

confidence: 99%

Site V Surgery for Temporal Migraine Headaches

Baldelli

Mangialardi

Raposio

2020

Plastic and Reconstructive Surgery - Global Open

View full text Add to dashboard Cite

Background: Auriculotemporal nerve is demonstrated to contribute to migraine pain in temporal area. In particular, its relationship with the superficial temporal artery in the soft tissues superficial to the temporal parietal fascia has attracted researchers’ attention for many decades. The objective of this review was to explore whether site V nerve surgical decompression is effective for pain relief in temporal area. Methods: A literature search, according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines, was conducted to evaluate the surgical treatment of auriculotemporal migraine. Inclusion was based on studies written in English, published between 2000 and February 2020, containing a diagnosis of migraine in compliance with the classification of the International Headache Society. The treatment must consist of surgical procedures involving the auriculotemporal nerve and/or arteries in site V, with outcome data available for at least 3 months. Results: Three hundred twenty-four records were identified after duplicates were removed, 31 full-text articles were assessed for eligibility, and 2 records were selected for inclusion. A total of 77 patients were included in the review. A direct approach at the anatomical site identified with careful physical examination and confirmed with a handheld Doppler probe is generally performed under local anesthesia. Blunt dissection to the superficial temporal fascia to expose the auriculotemporal nerve and the superficial temporal artery is followed by artery cauterization/ligament and eventual nerve transection/avulsion. Site V surgery results in a success rate from 79% to 97%. Conclusions: Despite the recent advances in extracranial trigger site surgery and a success rate (>50% improvement) from 79% to 97%, site V decompression is still poorly described. Elaborate randomized trials are needed with accurate reporting of patient selection, surgical procedure, adverse events, recurrencies or appearance of new trigger points, quality of life outcome, and longer follow-up times.

show abstract

Section: Discussionmentioning

confidence: 99%

Site V Surgery for Temporal Migraine Headaches

Baldelli

Mangialardi

Raposio

2020

Plastic and Reconstructive Surgery - Global Open

View full text Add to dashboard Cite

show abstract

“…Trigger site I migraine is most common 20 and originates from the irritation of the supraorbital (SON) and supratrochlear nerves (STN), as well as the terminal branches of the frontal nerve. Different anatomical studies have been conducted to better understand supraorbital and supratrochlear nerve anatomy and to identify their possible irritation points.…”

Section: Introductionmentioning

confidence: 99%

Decompression Surgery for Frontal Migraine Headache

Mangialardi

Baldelli

Salgarello

et al. 2020

Plastic and Reconstructive Surgery - Global Open

View full text Add to dashboard Cite

Introduction: Migraine headache (MH) is one of the most common diseases worldwide and pharmaceutical treatment is considered the gold standard. Nevertheless, one-third of patients suffering from migraine headaches are unresponsive to medical management and meet the criteria for “refractory migraines” classification. Surgical treatment of MH might represent a supplementary alternative for this category of patients when pharmaceutical treatment does not allow for satisfactory results. The goal of this article is to provide a comprehensive review of the literature regarding surgical treatment for site I migraine management. Methods: A literature search using PubMed, Medline, Cochrane and Google Scholar database according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines was conducted using the following MeSH terms: “frontal neuralgia,” “frontal trigger site treatment,” “frontal migraine surgery” and “frontal headache surgery” (period: 2000 -2020; last search on 12 March 2020). Results: Eighteen studies published between 2000 and 2019, with a total of 628 patients, were considered eligible. Between 68% and 93% of patients obtained satisfactory postoperative results. Complete migraine elimination rate ranged from 28.3% to 59%, and significant improvement (>50% reduction) rates varied from 26.5% to 60%. Conclusions: Our systematic review of the literature suggests that frontal trigger site nerve decompression could possibly be an effective strategy to treat migraine refractory patients, providing significant improvement of symptoms in a considerable percentage of patients.

show abstract

“…Preventive medication is usually saved for patients who have frequent attacks or a diagnosis of CM, as long-term use of analgesics can lead to the development of medication-overuse headache [ 2 ]. Some common medications used for long-term prevention are beta-blockers, antidepressants, calcium-channel blockers, anticonvulsants, and angiotensin-converting enzyme inhibitors [ 25 , 34 ]. OnabotulinumotoxinA, otherwise known as BOTOX, has also been an effective strategy that physicians have utilized for prophylactically treating CM headaches [ 35 ].…”

Section: Traditional Treatments For Migrainementioning

confidence: 99%

Acupuncture and Its Role in the Treatment of Migraine Headaches

et al. 2020

View full text Add to dashboard Cite

Acupuncture is a form of traditional Chinese medicine that is performed by placing needles or pressure in specific locations on a patient’s skin to achieve a therapeutic effect. Although used to treat a variety of disorders, one of the most common applications of acupuncture is to treat chronic pain, especially headache and migraine pain. Migraines are difficult to treat, and pharmacotherapies are often the first line of treatment, although these options have many unwanted side effects, such as exacerbation of headache pain in those with chronic migraine. Many complimentary and integrative therapies are available to treat migraine (including nutraceuticals, yoga, tai chi, and biofeedback), among which acupuncture as a treatment is gaining increasing attention. In this review, we provide an overview of the current understanding of both acupuncture and migraine and of current research investigating the effectiveness of acupuncture in treating migraine and chronic migraine.

show abstract

Migraine Treatment

Cited by 19 publications

References 33 publications

Site V Surgery for Temporal Migraine Headaches

Site V Surgery for Temporal Migraine Headaches

Decompression Surgery for Frontal Migraine Headache

Acupuncture and Its Role in the Treatment of Migraine Headaches

Contact Info

Product

Resources

About